Engineered Bacterial Spores Reveal New Protein Targets for Vaccines

Scientists have utilized engineered bacterial spores to identify new protein targets for developing enzymes and vaccines. This breakthrough leverages millions of years of biological evolution to efficiently create drugs and chemicals for medical use. The discovery promises to accelerate the development of treatments for various diseases through advanced bioengineering techniques.